Georg Rauter develops micro robots as tools for brain surgeons and dentists, and for operations on bones. He wants to establish Basel as a hub for medical robotics thanks to his collaborations with researchers in Switzerland and around the world.
When it comes to chronic infections and cancer, a particular type of immune cell plays a central role in our defenses. Researchers at the University of Basel have uncovered the key to the tenacity of these immune cells in coping with the marathon that is fighting a chronic infection. Their results lay the foundations for more effective therapies and vaccination strategies.
Fanny Lalot deceives others. Only within the scope of a study, however. The psychologist wants to find out how trust is built and broken. This is not her only research topic: Lalot seeks to shine a light on all sorts of human behavior.
Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the study data shows that a specific group of patients benefits the most from the drug.
The University Council has appointed Professor Andreas Lanz as Professor of Digital Marketing Analytics in the Faculty of Business and Economics. Three other professors are also promoted.
The Swiss National Science Foundation has awarded four Consolidator Grants to Basel researchers. The projects in the fields of Near and Middle Eastern studies, microbiology, philosophy and biomedicine will each receive around 1,7 million Swiss francs in funding.
The autoimmune disease multiple sclerosis can take a variety of courses. Determining the current and future progression of the disease is important in order to slow down its course as much as possible. Researchers at the University of Basel have presented a biomarker whose values in the blood allow such predictions.
A research group at the University of Basel has identified a gene that drives T lymphocytes to exhaustion. This finding opens up new approaches for more effective immunotherapies.
The Pfizer Research Prize is one of the most prestigious research awards in the field of medicine in Switzerland. This year, the Pfizer Research Prize Foundation has honored seven researchers from the Basel research hub with an award.
